Literature DB >> 10340986

Antimicrobial defensin peptides of the human ocular surface.

R J Haynes1, P J Tighe, H S Dua.   

Abstract

BACKGROUND/AIMS: The antimicrobial activity of the tear film exceeds the activity of its known constituents. The authors postulate that this excess activity is the result of antimicrobial peptides called defensins, and they aimed to look for defensins in the human eye.
METHODS: Evidence of defensin production was sought by reverse transcriptase polymerase chain reaction (RT-PCR). Intron spanning primers were designed for beta defensins 1 and 2, and alpha defensins 5 and 6. RT-PCR was performed on cornea, conjunctiva, and lacrimal gland samples, and reaction products were size fractionated and sequenced to confirm their identity. A monoclonal antibody was utilised for the detection of alpha defensins 1, 2, and 3 in tissue sections and in immunoblots of tears.
RESULTS: RT-PCR revealed beta defensin 1 message in samples of conjunctiva, cornea, and lacrimal gland. beta Defensin 2 message was detected in the conjunctiva and cornea but was absent from the lacrimal gland. alpha Defensin 5 and 6 message was absent in these tissues but alpha defensins 1, 2, and 3 were detected in normal tears, lacrimal gland, and inflamed conjunctiva by immunochemistry.
CONCLUSION: The data suggest the human eye innately produces a spectrum of antimicrobial defensin peptides. Defensins hold therapeutic potential in ocular infections as they have a broad spectrum of antimicrobial activity (bacteria fungi and viruses ) and accelerate epithelial healing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340986      PMCID: PMC1723065          DOI: 10.1136/bjo.83.6.737

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization.

Authors:  C P Hill; J Yee; M E Selsted; D Eisenberg
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

Review 2.  Defensins: endogenous antibiotic peptides of animal cells.

Authors:  R I Lehrer; T Ganz; M E Selsted
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Monocyte-chemotactic activity of defensins from human neutrophils.

Authors:  M C Territo; T Ganz; M E Selsted; R Lehrer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Defensins are mitogenic for epithelial cells and fibroblasts.

Authors:  C J Murphy; B A Foster; M J Mannis; M E Selsted; T W Reid
Journal:  J Cell Physiol       Date:  1993-05       Impact factor: 6.384

5.  Direct inactivation of viruses by human granulocyte defensins.

Authors:  K A Daher; M E Selsted; R I Lehrer
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

Review 6.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Authors:  R I Lehrer; A K Lichtenstein; T Ganz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  Paneth cells of the human small intestine express an antimicrobial peptide gene.

Authors:  D E Jones; C L Bevins
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

8.  Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.

Authors:  D E Jones; C L Bevins
Journal:  FEBS Lett       Date:  1993-01-04       Impact factor: 4.124

9.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Enteric defensins: antibiotic peptide components of intestinal host defense.

Authors:  M E Selsted; S I Miller; A H Henschen; A J Ouellette
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  58 in total

1.  [Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

2.  Commensal ocular bacteria degrade mucins.

Authors:  M Berry; A Harris; R Lumb; K Powell
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 3.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

4.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

5.  TLRs and NODs mRNA expression pattern in healthy mouse eye.

Authors:  S Rodríguez-Martínez; M E Cancino-Díaz; L Jiménez-Zamudio; E García-Latorre; J C Cancino-Díaz
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

6.  Glycoprotein 340 in normal human ocular surface tissues and tear film.

Authors:  Marcia M Jumblatt; Yoannis Imbert; William W Young; Gary N Foulks; Pamela S Steele; Donald R Demuth
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  A case of bilateral endophthalmitis and carriage of beta-defensin 1 44CC genotype.

Authors:  James Carter; Amanda J Churchill; Chris Gorman; Richard Haynes
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

Review 8.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

9.  Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.

Authors:  Maria Fluckinger; Hubertus Haas; Petra Merschak; Ben J Glasgow; Bernhard Redl
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.

Authors:  Emilia Ghelardi; Arianna Tavanti; Paola Davini; Francesco Celandroni; Sara Salvetti; Eva Parisio; Enrico Boldrini; Sonia Senesi; Mario Campa
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.